US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tiziana Life Sciences PLC

1.15

+0.01000.88%

Post-market: 1.160.0100+0.87%17:46 EDT

Volume:959.02K

Turnover:1.14M

Market Cap:146.05M

PE:-7.38

High:1.25

Open:1.14

Low:1.14

Close:1.14

52wk High:2.35

52wk Low:0.8663

Shares:127.00M

Float Shares:64.88M

Volume Ratio:0.60

T/O Rate:1.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1558

EPS(LYR):-0.1558

ROE:-924.32%

ROA:-115.96%

PB:2808.65

PE(LYR):-7.38

Loading ...

Overview Company News Filings

Tiziana Fully Enrolls Its Phase 2 Placebo Controlled Multiple Sclerosis Trial

THOMSON REUTERS

Sector Update: Healthcare Stocks Rise Tuesday Afternoon

MT Newswires Live

Tiziana Life Sciences announces updated intranasal foralumab data

Tiziana Life Sciences Says Multiple Sclerosis Therapy Shows Tolerability, Fatigue Improvement in Updated Clinical Data

MT Newswires Live

Tiziana reports positive expanded-access data for intranasal foralumab in non-active SPMS

Tiziana Life Sciences Ltd - Foralumab Well Tolerated With No New Safety Signals Identified

THOMSON REUTERS

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

THOMSON REUTERS

Tiziana Life Sciences Ltd - Intranasal Foralumab Well Tolerated Over Extended Treatment as of March 2026

THOMSON REUTERS

Tiziana Phase 2 trial for foralumab shows reduced brain inflammation

Tiziana FY25 net loss widens to USD 18.4 million; R&D expense rises to USD 10.28 million

Tiziana Life Sciences delays filing annual Form 20-F for 2025 fiscal year

Tiziana Life announces publication of preclinical data in bioRxiv preprint

Tiziana reports preclinical data showing intranasal foralumab eases Long COVID brain inflammation in mice

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-Cd3 Antibody Attenuates Long Covid Neuroinflammation and Improves Cognitive Function

THOMSON REUTERS

Tiziana presents Phase 2a intranasal foralumab MSA trial poster at World Parkinson Congress

Tiziana says preclinical data show intranasal foralumab reverses brain aging, boosts cognition

Tiziana Life Sciences Ltd. Director and 10% Owner Gabriele M. Cerrone Files Initial Beneficial Ownership Statement

BUZZ-Tiziana Life Sciences rises as nasal MS drug shows promise in early study

Tiziana reports biomarker data linking nasal foralumab to reduced CSF inflammation and microglial PET signal in na-SPMS patients with PIRA

Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates Csf Inflammation, Upregulates Neuroprotective Pathways, and Correlates With Reduced Microglial Activation on Pet Scans in Na-Spms Patients With Pira

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TLSA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLSA\",,,,,undefined,":{"symbol":"TLSA","market":"US","secType":"STK","nameCN":"Tiziana Life Sciences PLC","latestPrice":1.15,"timestamp":1787601600000,"preClose":1.14,"halted":0,"volume":959016,"hourTrading":{"tag":"盘后","latestPrice":1.16,"preClose":1.15,"latestTime":"17:46 EDT","volume":410,"amount":473.490017,"timestamp":1787607981736,"change":0.01,"changeRate":0.008696,"amplitude":0.017391},"delay":0,"changeRate":0.008771929824561412,"floatShares":64882543,"shares":127000000,"eps":-0.155821,"marketStatus":"Post-Mkt","change":0.01,"latestTime":"08-24 18:30:13 EDT","open":1.14,"high":1.25,"low":1.135,"amount":1137634.2644256002,"amplitude":0.100877,"askPrice":1.16,"askSize":219,"bidPrice":1.12,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.155821,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":2,"listingDate":1542690000000,"exchange":"NASDAQ","adjPreClose":1.14,"preHourTrading":{"tag":"盘前","latestPrice":1.1596,"preClose":1.14,"latestTime":"07:45 EDT","volume":197,"amount":227.0560142,"timestamp":1787571956605,"change":0.0196,"changeRate":0.017193,"amplitude":0.008772},"postHourTrading":{"tag":"盘后","latestPrice":1.16,"preClose":1.15,"latestTime":"17:46 EDT","volume":410,"amount":473.490017,"timestamp":1787607981736,"change":0.01,"changeRate":0.008696,"amplitude":0.017391},"volumeRatio":0.596593,"impliedVol":1.1411,"impliedVolPercentile":0.7849},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLSA\",,,,,undefined,":{"symbol":"TLSA","floatShares":64882543,"roa":"-115.96%","roe":"-924.32%","lyrEps":-0.155821,"volumeRatio":0.596593,"shares":127000000,"dividePrice":0,"high":1.25,"amplitude":0.100877,"preClose":1.14,"low":1.135,"week52Low":0.8663,"pbRate":"2808.65","week52High":2.35,"institutionHeld":0.0348,"latestPrice":1.15,"committee":0.802614,"eps":-0.155821,"divideRate":0,"volume":959016,"delay":0,"ttmEps":-0.155821,"open":1.14,"prevYearClose":1.49,"prevWeekClose":1.14,"prevMonthClose":1.03,"prevQuarterClose":1.28,"fiveDayClose":1.15,"twentyDayClose":0.9102,"sixtyDayClose":1.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-01","symbol":"TLSA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777608000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-10-03","symbol":"TLSA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1759464000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-04-26","symbol":"TLSA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1682481600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-12-27","symbol":"TLSA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1672117200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-10-21","symbol":"TLSA","type":"split","dateTimestamp":1634788800000,"forFactor":2,"toFactor":1,"ratio":2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLSA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1753243200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLSA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLSA","date":"2026-08-21","current":-7.561882,"percent":0.301155,"low":-23.489551,"twenty":-12.316663,"median":-5.280665,"eighty":-3.122466,"high":-1.599938,"avg":-7.053736,"sd":4.830425,"marketCap":144824289},"quantilePoints":[{"date":"2021-08-27","current":-5.886551,"twenty":-29.940608,"median":-13.361925,"eighty":-6.227199,"marketCap":153821475},{"date":"2021-09-03","current":-7.434448,"twenty":-29.940608,"median":-12.632617,"eighty":-6.209263,"marketCap":194269568},{"date":"2021-09-10","current":-6.806796,"twenty":-29.940608,"median":-12.157996,"eighty":-6.209263,"marketCap":177868376},{"date":"2021-09-17","current":-5.992303,"twenty":-29.940608,"median":-11.486643,"eighty":-6.20476,"marketCap":156584863},{"date":"2021-09-24","current":-3.773871,"twenty":-29.940608,"median":-10.638748,"eighty":-6.172148,"marketCap":142326538},{"date":"2021-10-01","current":-3.390537,"twenty":-29.785204,"median":-10.57874,"eighty":-6.141171,"marketCap":127869601},{"date":"2021-10-08","current":-3.800257,"twenty":-29.507712,"median":-10.420888,"eighty":-6.054586,"marketCap":143321663},{"date":"2021-10-15","current":-3.834618,"twenty":-29.006722,"median":-10.378475,"eighty":-6.001892,"marketCap":144617536},{"date":"2021-10-22","current":-3.895995,"twenty":-28.468479,"median":-10.126073,"eighty":-5.905987,"marketCap":146932278},{"date":"2021-10-29","current":-4.025001,"twenty":-28.187179,"median":-10.010739,"eighty":-5.888024,"marketCap":151797586},{"date":"2021-11-05","current":-3.973399,"twenty":-28.169927,"median":-9.825857,"eighty":-5.867998,"marketCap":149851463},{"date":"2021-11-12","current":-3.586379,"twenty":-28.092184,"median":-9.669215,"eighty":-5.82097,"marketCap":135255541},{"date":"2021-11-19","current":-3.586379,"twenty":-28.050688,"median":-9.669212,"eighty":-5.79835,"marketCap":135255541},{"date":"2021-11-26","current":-3.40577,"twenty":-28.028053,"median":-9.649075,"eighty":-5.788004,"marketCap":128444111},{"date":"2021-12-03","current":-2.734937,"twenty":-28.028053,"median":-9.580127,"eighty":-5.769339,"marketCap":103144513},{"date":"2021-12-10","current":-3.070354,"twenty":-27.934626,"median":-9.557293,"eighty":-5.747833,"marketCap":115794312},{"date":"2021-12-17","current":-2.427901,"twenty":-27.911269,"median":-9.542128,"eighty":-5.729154,"marketCap":91565082},{"date":"2021-12-23","current":-2.481052,"twenty":-27.911269,"median":-9.440069,"eighty":-5.727639,"marketCap":93569589},{"date":"2021-12-31","current":-2.476924,"twenty":-27.911269,"median":-9.327951,"eighty":-5.727615,"marketCap":93413899},{"date":"2022-01-07","current":-2.566712,"twenty":-27.911269,"median":-9.327951,"eighty":-5.708188,"marketCap":96800153},{"date":"2022-01-14","current":-2.141507,"twenty":-27.658291,"median":-9.327949,"eighty":-5.679838,"marketCap":80764100},{"date":"2022-01-21","current":-2.07107,"twenty":-27.528347,"median":-9.327948,"eighty":-5.678789,"marketCap":78107642},{"date":"2022-01-28","current":-2.066941,"twenty":-27.274921,"median":-9.327947,"eighty":-5.547981,"marketCap":77951952},{"date":"2022-02-04","current":-1.99573,"twenty":-27.09749,"median":-9.327946,"eighty":-5.503389,"marketCap":75266303},{"date":"2022-02-11","current":-1.909037,"twenty":-26.607405,"median":-9.32144,"eighty":-5.485214,"marketCap":71996816},{"date":"2022-02-18","current":-1.723784,"twenty":-26.511931,"median":-9.31493,"eighty":-5.478141,"marketCap":65010235},{"date":"2022-02-25","current":-1.728686,"twenty":-26.2397,"median":-9.189309,"eighty":-5.439725,"marketCap":65195117},{"date":"2022-03-04","current":-2.365204,"twenty":-26.062052,"median":-9.10044,"eighty":-5.30143,"marketCap":89200543},{"date":"2022-03-11","current":-2.683334,"twenty":-25.73,"median":-9.100437,"eighty":-5.301428,"marketCap":101198390},{"date":"2022-03-18","current":-2.99295,"twenty":-25.667305,"median":-9.100435,"eighty":-5.274161,"marketCap":112875128},{"date":"2022-03-25","current":-2.99295,"twenty":-25.34775,"median":-9.010383,"eighty":-5.149181,"marketCap":112875128},{"date":"2022-04-01","current":-2.709135,"twenty":-25.094045,"median":-8.934052,"eighty":-5.111851,"marketCap":102171452},{"date":"2022-04-08","current":-2.669143,"twenty":-24.821013,"median":-8.808095,"eighty":-5.099469,"marketCap":100663207},{"date":"2022-04-14","current":-2.450865,"twenty":-24.617472,"median":-8.701697,"eighty":-5.099468,"marketCap":92431107},{"date":"2022-04-22","current":-2.580129,"twenty":-24.572793,"median":-8.530447,"eighty":-5.054166,"marketCap":97306145},{"date":"2022-04-29","current":-2.631732,"twenty":-24.448686,"median":-8.421145,"eighty":-4.981135,"marketCap":99252267},{"date":"2022-05-06","current":-2.219169,"twenty":-24.026739,"median":-8.300812,"eighty":-4.884659,"marketCap":83693015},{"date":"2022-05-13","current":-2.018948,"twenty":-23.746739,"median":-8.187006,"eighty":-4.823968,"marketCap":76141961},{"date":"2022-05-20","current":-2.218911,"twenty":-23.579959,"median":-8.071598,"eighty":-4.702321,"marketCap":83683284},{"date":"2022-05-27","current":-2.882736,"twenty":-23.53692,"median":-7.984331,"eighty":-4.689921,"marketCap":67505038},{"date":"2022-06-03","current":-3.406612,"twenty":-23.53692,"median":-7.928646,"eighty":-4.654904,"marketCap":79772638},{"date":"2022-06-10","current":-3.324067,"twenty":-23.53692,"median":-7.867288,"eighty":-4.544041,"marketCap":77839686},{"date":"2022-06-17","current":-3.493961,"twenty":-23.53692,"median":-7.811077,"eighty":-4.543869,"marketCap":81818091},{"date":"2022-06-24","current":-3.559473,"twenty":-23.54768,"median":-7.796399,"eighty":-4.531659,"marketCap":83352180},{"date":"2022-07-01","current":-3.100891,"twenty":-23.54768,"median":-7.728087,"eighty":-4.467288,"marketCap":72613555},{"date":"2022-07-08","current":-3.624985,"twenty":-23.54768,"median":-7.721332,"eighty":-4.415906,"marketCap":84886269},{"date":"2022-07-15","current":-3.231691,"twenty":-23.54768,"median":-7.661463,"eighty":-4.392613,"marketCap":75676518},{"date":"2022-07-22","current":-3.319263,"twenty":-23.54768,"median":-7.590346,"eighty":-4.392612,"marketCap":77727186},{"date":"2022-07-29","current":-3.193481,"twenty":-23.54768,"median":-7.556634,"eighty":-4.392611,"marketCap":74781735},{"date":"2022-08-05","current":-3.320137,"twenty":-23.54768,"median":-7.506302,"eighty":-4.367089,"marketCap":77747641},{"date":"2022-08-12","current":-2.926629,"twenty":-23.54768,"median":-7.490514,"eighty":-4.301264,"marketCap":68532878},{"date":"2022-08-19","current":-3.318822,"twenty":-23.54768,"median":-7.438492,"eighty":-4.17743,"marketCap":77716857},{"date":"2022-08-26","current":-3.275589,"twenty":-23.54768,"median":-7.3942,"eighty":-4.019074,"marketCap":76704460},{"date":"2022-09-02","current":-3.201342,"twenty":-23.505494,"median":-7.377655,"eighty":-3.985228,"marketCap":74965826},{"date":"2022-09-09","current":-3.456401,"twenty":-23.505494,"median":-7.341914,"eighty":-3.879088,"marketCap":80938546},{"date":"2022-09-16","current":-2.402098,"twenty":-23.505494,"median":-7.324932,"eighty":-3.846329,"marketCap":56249937},{"date":"2022-09-23","current":-3.406612,"twenty":-23.505494,"median":-7.28035,"eighty":-3.805613,"marketCap":79772638},{"date":"2022-09-30","current":-3.406612,"twenty":-23.434212,"median":-7.247329,"eighty":-3.781352,"marketCap":79772638},{"date":"2022-10-07","current":-3.406612,"twenty":-23.220478,"median":-7.166595,"eighty":-3.759386,"marketCap":79772638},{"date":"2022-10-14","current":-3.214008,"twenty":-23.083534,"median":-7.126458,"eighty":-3.725029,"marketCap":75262416},{"date":"2022-10-21","current":-3.159851,"twenty":-22.806965,"median":-6.99243,"eighty":-3.687976,"marketCap":73994236},{"date":"2022-10-28","current":-3.064204,"twenty":-22.453079,"median":-6.976128,"eighty":-3.646668,"marketCap":71754465},{"date":"2022-11-04","current":-2.967683,"twenty":-21.973415,"median":-6.960131,"eighty":-3.627468,"marketCap":69494241},{"date":"2022-11-11","current":-3.02577,"twenty":-21.782912,"median":-6.893952,"eighty":-3.621991,"marketCap":70854466},{"date":"2022-11-18","current":-2.838407,"twenty":-21.346064,"median":-6.834314,"eighty":-3.586379,"marketCap":66466971},{"date":"2022-11-25","current":-2.751931,"twenty":-21.097851,"median":-6.801722,"eighty":-3.562011,"marketCap":64441974},{"date":"2022-12-02","current":-2.773332,"twenty":-20.849642,"median":-6.715009,"eighty":-3.543663,"marketCap":64943109},{"date":"2022-12-09","current":-2.642308,"twenty":-20.15466,"median":-6.694123,"eighty":-3.527252,"marketCap":61874931},{"date":"2022-12-16","current":-2.620471,"twenty":-19.856804,"median":-6.694121,"eighty":-3.493961,"marketCap":61363568},{"date":"2022-12-23","current":-2.620471,"twenty":-19.534135,"median":-6.673771,"eighty":-3.454305,"marketCap":61363568},{"date":"2022-12-30","current":-5.55835,"twenty":-18.976137,"median":-6.64476,"eighty":-3.441552,"marketCap":60663833},{"date":"2023-01-06","current":-5.849966,"twenty":-18.976137,"median":-6.636781,"eighty":-3.441552,"marketCap":63846531},{"date":"2023-01-13","current":-6.221452,"twenty":-18.976137,"median":-6.563672,"eighty":-3.441552,"marketCap":67900922},{"date":"2023-01-20","current":-5.840679,"twenty":-18.976137,"median":-6.471801,"eighty":-3.441552,"marketCap":63745171},{"date":"2023-01-27","current":-6.011562,"twenty":-18.976137,"median":-6.45636,"eighty":-3.441552,"marketCap":65610191},{"date":"2023-02-03","current":-5.572281,"twenty":-18.976137,"median":-6.437448,"eighty":-3.441552,"marketCap":60815873},{"date":"2023-02-10","current":-5.200795,"twenty":-18.976137,"median":-6.378693,"eighty":-3.441552,"marketCap":56761481},{"date":"2023-02-17","current":-5.386538,"twenty":-18.976137,"median":-6.361714,"eighty":-3.441552,"marketCap":58788677},{"date":"2023-02-24","current":-5.200795,"twenty":-18.976137,"median":-6.346892,"eighty":-3.441552,"marketCap":56761481},{"date":"2023-03-03","current":-5.085635,"twenty":-18.976137,"median":-6.311222,"eighty":-3.441552,"marketCap":55504620},{"date":"2023-03-10","current":-5.384681,"twenty":-18.976137,"median":-6.26484,"eighty":-3.441552,"marketCap":58768405},{"date":"2023-03-17","current":-6.253028,"twenty":-18.976137,"median":-6.2385,"eighty":-3.441552,"marketCap":68245545},{"date":"2023-03-24","current":-7.801193,"twenty":-18.976137,"median":-6.2385,"eighty":-3.441552,"marketCap":85142222},{"date":"2023-03-31","current":-10.137836,"twenty":-18.92005,"median":-6.260696,"eighty":-3.446356,"marketCap":110644345},{"date":"2023-04-06","current":-8.673255,"twenty":-18.92005,"median":-6.309931,"eighty":-3.446356,"marketCap":94659906},{"date":"2023-04-14","current":-10.030106,"twenty":-18.976137,"median":-6.322484,"eighty":-3.441552,"marketCap":109468572},{"date":"2023-04-21","current":-10.581761,"twenty":-18.976137,"median":-6.361714,"eighty":-3.441552,"marketCap":115489343},{"date":"2023-04-28","current":-5.29741,"twenty":-18.976137,"median":-6.361716,"eighty":-3.441552,"marketCap":81564222},{"date":"2023-05-05","current":-5.063099,"twenty":-18.976137,"median":-6.361716,"eighty":-3.441552,"marketCap":77956529},{"date":"2023-05-12","current":-5.357085,"twenty":-18.976137,"median":-6.361716,"eighty":-3.441552,"marketCap":82483037},{"date":"2023-05-24","current":-4.965103,"twenty":-19.22201,"median":-6.423248,"eighty":-3.418928,"marketCap":76447693},{"date":"2023-06-02","current":-5.891487,"twenty":-19.347214,"median":-6.437449,"eighty":-3.406612,"marketCap":90711223},{"date":"2023-06-05","current":-6.729021,"twenty":-19.347214,"median":-6.439649,"eighty":-3.406612,"marketCap":103606742},{"date":"2023-06-16","current":-5.128429,"twenty":-19.459674,"median":-6.456748,"eighty":-3.406612,"marketCap":78962419},{"date":"2023-06-23","current":-4.705089,"twenty":-19.484495,"median":-6.457136,"eighty":-3.406612,"marketCap":72444248},{"date":"2023-06-30","current":-4.442461,"twenty":-19.509315,"median":-6.459915,"eighty":-3.406612,"marketCap":68400567},{"date":"2023-07-07","current":-4.351652,"twenty":-19.509315,"median":-6.459915,"eighty":-3.406612,"marketCap":67002379},{"date":"2023-07-14","current":-4.448994,"twenty":-19.509315,"median":-6.459915,"eighty":-3.406612,"marketCap":68501156},{"date":"2023-07-21","current":-4.405222,"twenty":-19.509315,"median":-6.459915,"eighty":-3.406612,"marketCap":67827209},{"date":"2023-07-28","current":-4.416329,"twenty":-19.509315,"median":-6.459915,"eighty":-3.406612,"marketCap":67998211},{"date":"2023-08-04","current":-4.241897,"twenty":-19.509315,"median":-6.459915,"eighty":-3.406612,"marketCap":65312483},{"date":"2023-08-11","current":-4.181139,"twenty":-19.509315,"median":-6.459915,"eighty":-3.406612,"marketCap":64377004},{"date":"2023-08-18","current":-4.910226,"twenty":-19.509315,"median":-6.456748,"eighty":-3.406612,"marketCap":75602745},{"date":"2023-08-25","current":-4.441154,"twenty":-19.509315,"median":-6.437449,"eighty":-3.406612,"marketCap":68380449},{"date":"2023-09-01","current":-4.749513,"twenty":-19.509315,"median":-6.361716,"eighty":-3.406612,"marketCap":73128253},{"date":"2023-09-08","current":-4.782178,"twenty":-19.509315,"median":-6.361714,"eighty":-3.406612,"marketCap":73631199},{"date":"2023-09-15","current":-4.641718,"twenty":-19.509315,"median":-6.317045,"eighty":-3.406612,"marketCap":71468534},{"date":"2023-09-22","current":-4.507131,"twenty":-19.509315,"median":-6.299431,"eighty":-3.406612,"marketCap":69396298},{"date":"2023-09-29","current":-4.382357,"twenty":-19.509315,"median":-6.246555,"eighty":-3.406612,"marketCap":67475148},{"date":"2023-10-06","current":-4.446381,"twenty":-19.509315,"median":-6.19849,"eighty":-3.406612,"marketCap":68460921},{"date":"2023-10-13","current":-4.833136,"twenty":-19.509315,"median":-6.160907,"eighty":-3.406612,"marketCap":74415793},{"date":"2023-10-20","current":-4.3118,"twenty":-19.509315,"median":-6.131118,"eighty":-3.406612,"marketCap":66388786},{"date":"2023-10-27","current":-4.187679,"twenty":-19.583775,"median":-6.058777,"eighty":-3.406612,"marketCap":64477694},{"date":"2023-11-03","current":-4.275868,"twenty":-19.583775,"median":-6.008284,"eighty":-3.406612,"marketCap":65835546},{"date":"2023-11-10","current":-3.985149,"twenty":-19.583775,"median":-5.908617,"eighty":-3.406612,"marketCap":61359332},{"date":"2023-11-17","current":-3.593167,"twenty":-19.583775,"median":-5.891412,"eighty":-3.406612,"marketCap":55323988},{"date":"2023-11-24","current":-3.593167,"twenty":-19.583775,"median":-5.849966,"eighty":-3.406612,"marketCap":55323988},{"date":"2023-12-01","current":-3.854488,"twenty":-19.583775,"median":-5.832321,"eighty":-3.406612,"marketCap":59347551},{"date":"2023-12-08","current":-3.952483,"twenty":-19.558955,"median":-5.805779,"eighty":-3.406612,"marketCap":60856387},{"date":"2023-12-15","current":-3.994295,"twenty":-19.558955,"median":-5.77612,"eighty":-3.406612,"marketCap":61500157},{"date":"2023-12-22","current":-3.977962,"twenty":-19.558955,"median":-5.746632,"eighty":-3.406612,"marketCap":61248684},{"date":"2023-12-29","current":-3.716641,"twenty":-19.583775,"median":-5.730591,"eighty":-3.406612,"marketCap":57225121},{"date":"2024-01-05","current":-3.902343,"twenty":-19.608595,"median":-5.727927,"eighty":-3.406612,"marketCap":60084382},{"date":"2024-01-12","current":-2.830078,"twenty":-19.608595,"median":-5.712591,"eighty":-3.406175,"marketCap":55189360},{"date":"2024-01-19","current":-3.086236,"twenty":-19.608596,"median":-5.716249,"eighty":-3.384862,"marketCap":60184690},{"date":"2024-01-26","current":-2.90672,"twenty":-19.608595,"median":-5.712591,"eighty":-3.362501,"marketCap":56683947},{"date":"2024-02-02","current":-2.71383,"twenty":-19.608595,"median":-5.712591,"eighty":-3.321884,"marketCap":52922404},{"date":"2024-02-09","current":-2.695313,"twenty":-19.608595,"median":-5.712591,"eighty":-3.308781,"marketCap":52561296},{"date":"2024-02-16","current":-2.739035,"twenty":-19.608595,"median":-5.712591,"eighty":-3.275589,"marketCap":53413912},{"date":"2024-02-23","current":-2.623301,"twenty":-19.608595,"median":-5.712591,"eighty":-3.255935,"marketCap":51156986},{"date":"2024-03-01","current":-2.472075,"twenty":-19.583775,"median":-5.708932,"eighty":-3.234535,"marketCap":48207936},{"date":"2024-03-08","current":-2.668051,"twenty":-19.583775,"median":-5.708932,"eighty":-3.225201,"marketCap":52029664},{"date":"2024-03-15","current":-2.610956,"twenty":-19.583775,"median":-5.708932,"eighty":-3.210863,"marketCap":50916247},{"date":"2024-03-22","current":-2.386689,"twenty":-19.583775,"median":-5.708932,"eighty":-3.199333,"marketCap":46542827},{"date":"2024-03-28","current":-2.144934,"twenty":-19.583775,"median":-5.708932,"eighty":-3.188676,"marketCap":41828359},{"date":"2024-04-05","current":-2.297703,"twenty":-19.608595,"median":-5.712591,"eighty":-3.17077,"marketCap":44807501},{"date":"2024-04-12","current":-2.338724,"twenty":-19.608595,"median":-5.679838,"eighty":-3.147757,"marketCap":45607456},{"date":"2024-04-19","current":-3.291985,"twenty":-19.608595,"median":-5.626178,"eighty":-3.144565,"marketCap":64197002},{"date":"2024-04-26","current":-4.326389,"twenty":-19.583775,"median":-5.57321,"eighty":-3.144827,"marketCap":84368904},{"date":"2024-05-03","current":-3.626842,"twenty":-19.583775,"median":-5.553076,"eighty":-3.144827,"marketCap":70727041},{"date":"2024-05-10","current":-3.291985,"twenty":-19.583775,"median":-5.489722,"eighty":-3.144827,"marketCap":64197002},{"date":"2024-05-17","current":-3.502878,"twenty":-19.583775,"median":-5.472592,"eighty":-3.144215,"marketCap":68309623},{"date":"2024-05-24","current":-4.199763,"twenty":-19.583775,"median":-5.405826,"eighty":-3.144215,"marketCap":74298000},{"date":"2024-05-31","current":-5.329792,"twenty":-19.583775,"median":-5.373418,"eighty":-3.144215,"marketCap":94289347},{"date":"2024-06-07","current":-5.738185,"twenty":-19.583775,"median":-5.373418,"eighty":-3.144215,"marketCap":101514234},{"date":"2024-06-14","current":-4.177399,"twenty":-19.608595,"median":-5.335876,"eighty":-3.144128,"marketCap":73902362},{"date":"2024-06-21","current":-4.51423,"twenty":-19.608596,"median":-5.29741,"eighty":-3.144041,"marketCap":79861247},{"date":"2024-06-28","current":-5.049603,"twenty":-19.6086,"median":-5.292247,"eighty":-3.143779,"marketCap":89332525},{"date":"2024-07-05","current":-4.734003,"twenty":-19.6086,"median":-5.274707,"eighty":-3.143779,"marketCap":83749243},{"date":"2024-07-12","current":-4.705312,"twenty":-19.6086,"median":-5.226424,"eighty":-3.143779,"marketCap":83241671},{"date":"2024-07-15","current":-4.636454,"twenty":-19.6086,"median":-5.225937,"eighty":-3.143779,"marketCap":82023501},{"date":"2024-08-02","current":-5.967713,"twenty":-19.754043,"median":-5.200639,"eighty":-3.12299,"marketCap":105574803},{"date":"2024-08-09","current":-7.488332,"twenty":-19.754043,"median":-5.200639,"eighty":-3.12299,"marketCap":132476075},{"date":"2024-08-16","current":-6.771059,"twenty":-19.754043,"median":-5.200639,"eighty":-3.12299,"marketCap":119786796},{"date":"2024-08-23","current":-7.172731,"twenty":-19.754043,"median":-5.200795,"eighty":-3.12299,"marketCap":126892792},{"date":"2024-08-30","current":-6.19724,"twenty":-19.754043,"median":-5.210722,"eighty":-3.12299,"marketCap":109635372},{"date":"2024-09-06","current":-4.937134,"twenty":-19.754043,"median":-5.225448,"eighty":-3.12299,"marketCap":87342846},{"date":"2024-09-13","current":-5.326757,"twenty":-19.754043,"median":-5.200795,"eighty":-3.12299,"marketCap":94235663},{"date":"2024-09-20","current":-6.348728,"twenty":-19.754043,"median":-5.199857,"eighty":-3.12299,"marketCap":112315348},{"date":"2024-09-27","current":-5.967713,"twenty":-19.754043,"median":-5.199857,"eighty":-3.12299,"marketCap":105574803},{"date":"2024-10-04","current":-5.645227,"twenty":-19.754043,"median":-5.199857,"eighty":-3.12299,"marketCap":99869703},{"date":"2024-10-11","current":-5.27913,"twenty":-19.754043,"median":-5.200795,"eighty":-3.12299,"marketCap":93393095},{"date":"2024-10-18","current":-5.141414,"twenty":-19.754043,"median":-5.225448,"eighty":-3.12299,"marketCap":90956753},{"date":"2024-10-25","current":-8.172209,"twenty":-19.754043,"median":-5.273392,"eighty":-3.12299,"marketCap":112188089},{"date":"2024-10-31","current":-8.807386,"twenty":-19.754043,"median":-5.27913,"eighty":-3.12299,"marketCap":120907796},{"date":"2024-11-08","current":-6.792137,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":93242452},{"date":"2024-11-15","current":-6.89887,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":94707691},{"date":"2024-11-22","current":-7.23997,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":99390306},{"date":"2024-11-29","current":-7.109352,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":97597182},{"date":"2024-12-06","current":-8.105159,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":111267620},{"date":"2024-12-13","current":-7.46946,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":102540747},{"date":"2024-12-20","current":-6.611267,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":90759470},{"date":"2024-12-27","current":-5.559185,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":76316497},{"date":"2025-01-03","current":-5.409796,"twenty":-19.788296,"median":-5.293202,"eighty":-3.122903,"marketCap":74265682},{"date":"2025-01-10","current":-5.848428,"twenty":-19.82255,"median":-5.292738,"eighty":-3.122815,"marketCap":80287223},{"date":"2025-01-17","current":-6.039138,"twenty":-19.82255,"median":-5.292738,"eighty":-3.122815,"marketCap":82905285},{"date":"2025-01-24","current":-7.032417,"twenty":-19.82255,"median":-5.292738,"eighty":-3.122815,"marketCap":96541023},{"date":"2025-01-31","current":-5.466214,"twenty":-19.82255,"median":-5.292738,"eighty":-3.122815,"marketCap":75040191},{"date":"2025-02-07","current":-5.109428,"twenty":-19.82255,"median":-5.290607,"eighty":-3.122815,"marketCap":70142234},{"date":"2025-02-14","current":-5.880213,"twenty":-19.82255,"median":-5.290607,"eighty":-3.122815,"marketCap":80723567},{"date":"2025-02-21","current":-7.151611,"twenty":-19.82255,"median":-5.290607,"eighty":-3.122815,"marketCap":98177311},{"date":"2025-02-28","current":-8.979245,"twenty":-19.82255,"median":-5.290607,"eighty":-3.122815,"marketCap":123267069},{"date":"2025-03-07","current":-11.919351,"twenty":-19.856803,"median":-5.28573,"eighty":-3.122728,"marketCap":163628853},{"date":"2025-03-14","current":-11.760426,"twenty":-19.856803,"median":-5.28573,"eighty":-3.122728,"marketCap":161447134},{"date":"2025-03-21","current":-10.250642,"twenty":-19.856803,"median":-5.28573,"eighty":-3.122728,"marketCap":140720813},{"date":"2025-03-28","current":-9.058707,"twenty":-19.856803,"median":-5.28573,"eighty":-3.122728,"marketCap":124357928},{"date":"2025-04-04","current":-8.105159,"twenty":-19.856803,"median":-5.28573,"eighty":-3.122728,"marketCap":111267620},{"date":"2025-04-11","current":-6.198063,"twenty":-19.82255,"median":-5.290607,"eighty":-3.122815,"marketCap":85087003},{"date":"2025-04-17","current":-7.072148,"twenty":-19.82255,"median":-5.290607,"eighty":-3.122815,"marketCap":97086452},{"date":"2025-04-25","current":-11.442577,"twenty":-19.856803,"median":-5.28573,"eighty":-3.122728,"marketCap":157083698},{"date":"2025-05-02","current":-10.250642,"twenty":-19.856803,"median":-5.28573,"eighty":-3.122728,"marketCap":140720813},{"date":"2025-05-09","current":-13.885165,"twenty":-19.856803,"median":-5.28573,"eighty":-3.122728,"marketCap":164719712},{"date":"2025-05-16","current":-13.06019,"twenty":-19.608601,"median":-5.28573,"eighty":-3.122728,"marketCap":154933037},{"date":"2025-05-23","current":-12.872274,"twenty":-18.739856,"median":-5.28573,"eighty":-3.122728,"marketCap":152703785},{"date":"2025-05-30","current":-12.966232,"twenty":-14.845396,"median":-5.28573,"eighty":-3.122728,"marketCap":153818411},{"date":"2025-06-06","current":-13.248107,"twenty":-13.885165,"median":-5.28573,"eighty":-3.122728,"marketCap":157162289},{"date":"2025-06-13","current":-13.342065,"twenty":-13.436023,"median":-5.28573,"eighty":-3.122728,"marketCap":158276916},{"date":"2025-06-20","current":-15.033313,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":178340187},{"date":"2025-06-27","current":-16.72456,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":198403458},{"date":"2025-07-03","current":-14.187689,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":168308551},{"date":"2025-07-11","current":-13.811856,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":163850046},{"date":"2025-07-18","current":-14.187689,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":168308551},{"date":"2025-07-25","current":-16.348727,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":193944953},{"date":"2025-08-01","current":-23.489551,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":278656542},{"date":"2025-08-08","current":-19.637265,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":232956869},{"date":"2025-08-15","current":-18.791641,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":222925234},{"date":"2025-08-22","current":-18.133933,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":215122850},{"date":"2025-08-29","current":-17.194351,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":203976589},{"date":"2025-09-05","current":-14.845396,"twenty":-13.436023,"median":-5.280759,"eighty":-3.122553,"marketCap":176110934},{"date":"2025-09-12","current":-16.818518,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":199518084},{"date":"2025-09-19","current":-16.72456,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":198403458},{"date":"2025-09-26","current":-19.449348,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":230727617},{"date":"2025-10-03","current":-18.791641,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":222925234},{"date":"2025-10-10","current":-19.709924,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":253095134},{"date":"2025-10-17","current":-18.692041,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":240024494},{"date":"2025-10-24","current":-17.581622,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":225765613},{"date":"2025-10-31","current":-17.026413,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":218636172},{"date":"2025-11-07","current":-16.656274,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":213883212},{"date":"2025-11-14","current":-15.268251,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":196059611},{"date":"2025-11-21","current":-14.944379,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":191900771},{"date":"2025-11-28","current":-16.656274,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":213883212},{"date":"2025-12-05","current":-16.378669,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":210318492},{"date":"2025-12-12","current":-15.915995,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":204377292},{"date":"2025-12-19","current":-13.325019,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":171106570},{"date":"2025-12-26","current":-14.157833,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":181800730},{"date":"2026-01-02","current":-13.787693,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":177047770},{"date":"2026-01-09","current":-13.695158,"twenty":-13.436023,"median":-5.280852,"eighty":-3.122641,"marketCap":175859530},{"date":"2026-01-16","current":-13.417554,"twenty":-13.342065,"median":-5.280852,"eighty":-3.122641,"marketCap":172294810},{"date":"2026-01-23","current":-16.188136,"twenty":-13.342065,"median":-5.280852,"eighty":-3.122641,"marketCap":207871851},{"date":"2026-01-30","current":-15.902065,"twenty":-13.342065,"median":-5.280852,"eighty":-3.122641,"marketCap":204198411},{"date":"2026-02-06","current":-12.622264,"twenty":-13.342065,"median":-5.280852,"eighty":-3.122641,"marketCap":162082488},{"date":"2026-02-13","current":-13.218591,"twenty":-13.342065,"median":-5.280852,"eighty":-3.122641,"marketCap":169739929},{"date":"2026-02-20","current":-13.914306,"twenty":-13.342065,"median":-5.280852,"eighty":-3.122641,"marketCap":178673609},{"date":"2026-02-27","current":-14.510634,"twenty":-13.262081,"median":-5.280852,"eighty":-3.122641,"marketCap":186331050},{"date":"2026-03-06","current":-14.311858,"twenty":-13.262081,"median":-5.280852,"eighty":-3.122641,"marketCap":183778570},{"date":"2026-03-13","current":-12.522876,"twenty":-13.22137,"median":-5.280852,"eighty":-3.122641,"marketCap":160806248},{"date":"2026-03-20","current":-12.522876,"twenty":-12.976949,"median":-5.280852,"eighty":-3.122641,"marketCap":160806248},{"date":"2026-03-27","current":-12.423488,"twenty":-12.881905,"median":-5.280852,"eighty":-3.122641,"marketCap":159530008},{"date":"2026-04-02","current":-12.423488,"twenty":-12.732985,"median":-5.280852,"eighty":-3.122641,"marketCap":159530008},{"date":"2026-04-10","current":-12.522876,"twenty":-12.542754,"median":-5.280852,"eighty":-3.122641,"marketCap":160806248},{"date":"2026-04-17","current":-13.317979,"twenty":-12.522876,"median":-5.280852,"eighty":-3.122641,"marketCap":171016169},{"date":"2026-04-24","current":-12.224712,"twenty":-12.433908,"median":-5.280852,"eighty":-3.122641,"marketCap":156977528},{"date":"2026-05-01","current":-12.721652,"twenty":-12.423488,"median":-5.280852,"eighty":-3.122641,"marketCap":163358728},{"date":"2026-05-08","current":-10.455876,"twenty":-12.343978,"median":-5.280852,"eighty":-3.122641,"marketCap":192712250},{"date":"2026-05-15","current":-10.040411,"twenty":-12.316663,"median":-5.280852,"eighty":-3.122641,"marketCap":185054810},{"date":"2026-05-22","current":-10.109655,"twenty":-12.316663,"median":-5.280852,"eighty":-3.122641,"marketCap":186331050},{"date":"2026-05-29","current":-10.243004,"twenty":-12.316663,"median":-5.280759,"eighty":-3.122553,"marketCap":188788805},{"date":"2026-06-05","current":-8.91001,"twenty":-12.316663,"median":-5.280852,"eighty":-3.122641,"marketCap":164220399},{"date":"2026-06-12","current":-7.927804,"twenty":-12.316663,"median":-5.280852,"eighty":-3.122641,"marketCap":146117363},{"date":"2026-06-18","current":-7.577017,"twenty":-12.316663,"median":-5.280852,"eighty":-3.122641,"marketCap":139651993},{"date":"2026-06-26","current":-7.927804,"twenty":-12.316663,"median":-5.280759,"eighty":-3.122553,"marketCap":146117363},{"date":"2026-07-02","current":-8.62938,"twenty":-12.316663,"median":-5.280759,"eighty":-3.122553,"marketCap":159048103},{"date":"2026-07-10","current":-8.839853,"twenty":-12.316663,"median":-5.280759,"eighty":-3.122553,"marketCap":162927325},{"date":"2026-07-17","current":-7.717332,"twenty":-12.316663,"median":-5.280759,"eighty":-3.122553,"marketCap":142238141},{"date":"2026-07-24","current":-7.156071,"twenty":-12.316663,"median":-5.280759,"eighty":-3.122553,"marketCap":131893549},{"date":"2026-07-31","current":-6.805283,"twenty":-12.316663,"median":-5.280665,"eighty":-3.122466,"marketCap":125428178},{"date":"2026-08-07","current":-6.835451,"twenty":-12.316663,"median":-5.280665,"eighty":-3.122466,"marketCap":125984200},{"date":"2026-08-14","current":-7.296386,"twenty":-12.316663,"median":-5.280665,"eighty":-3.122466,"marketCap":134479697},{"date":"2026-08-21","current":-7.857647,"twenty":-12.316663,"median":-5.280665,"eighty":-3.122466,"marketCap":144824289}],"updateTime":1787589963713},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLSA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637733754","title":"Tiziana Fully Enrolls Its Phase 2 Placebo Controlled Multiple Sclerosis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637733754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637733754?lang=en_us&edition=fundamental","pubTime":"2026-05-21 23:00","pubTimestamp":1779375600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA6F8BCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636865778","title":"Sector Update: Healthcare Stocks Rise Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2636865778","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636865778?lang=en_us&edition=fundamental","pubTime":"2026-05-20 02:02","pubTimestamp":1779213753,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.1% and the State Street Healthcare Select Sector SPDR ETF (XLV) gaining 1.2%.The iShares Biotechnology ETF (IBB) incre","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0689472784.USD","BK4550","XBI","LU2023250843.SGD","IBB","LU0266013472.USD","LU2237443978.SGD","MTVA","IE00BWXC8680.SGD","IE00B4R5TH58.HKD","LU2362541513.USD","LU0234572021.USD","LU0640476718.USD","JPMO","LU2054465674.USD","TLSA","LABU","LU0353189763.USD","BK4516","LU1670627923.USD","JPO","LU1244550494.USD","LU0203347892.USD","IE00BJTD4N35.SGD","IE0034235295.USD","XLV","BK4139","LU2265009873.SGD","IE00B1XK9C88.USD","LU1718418525.SGD","LU0208291251.USD","LU2505996509.AUD","HCSG","IE0009355771.USD","JPX","LU0203345920.USD","LU1791710582.SGD","LU1989772840.SGD","LU0149725797.USD","RLAY","BSX","LU0106261372.USD","LU2491049909.HKD","BK4581","LU2552382058.USD","LU1057294990.SGD","LU2746668461.USD","BSX.AU","LU2746668974.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636856984","title":"Tiziana Life Sciences announces updated intranasal foralumab data","url":"https://stock-news.laohu8.com/highlight/detail?id=2636856984","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636856984?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:13","pubTimestamp":1779192808,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) announced updated clinical data from its ongoing expanded access program evaluating intranasal foralumab in 14 patient...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-announces-updated-intranasal-foralumab-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-announces-updated-intranasal-foralumab-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636855307","title":"Tiziana Life Sciences Says Multiple Sclerosis Therapy Shows Tolerability, Fatigue Improvement in Updated Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2636855307","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636855307?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:51","pubTimestamp":1779191517,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences'  intranasal foralumab showed good long-term tolerability and fatigue improvement in an expanded access program involving 14 patients with non-active secondary progressive multiple sclerosis based on updated clinical data, the biotechnology company said Tuesday.Multiple sclerosis is an autoimmune condition of the central nervous system.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636938858","title":"Tiziana reports positive expanded-access data for intranasal foralumab in non-active SPMS","url":"https://stock-news.laohu8.com/highlight/detail?id=2636938858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636938858?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188451,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences released updated clinical data from its ongoing expanded-access program of intranasal foralumab in 14 patients with non-active secondary progressive multiple sclerosis, covering results first presented in March 2025 through March 2026.The update showed the treatment remained well tolerated over longer use, with no new safety concerns flagged.Patients showed favorable trends toward stabilizing disability, with many also reporting clinically meaningful improvements in fatigue.The company framed the findings as supportive of further development, while noting the small expanded-access dataset limits the strength of conclusions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL62zv5C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4112","SG9999014039.USD","IE00BN0W2V16.EUR","BK4139","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","TLSA","SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","BK4585","BK4588","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636858989","title":"Tiziana Life Sciences Ltd - Foralumab Well Tolerated With No New Safety Signals Identified","url":"https://stock-news.laohu8.com/highlight/detail?id=2636858989","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636858989?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUASFM8S:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636785862","title":"Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2636785862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636785862?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUASFM8S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636623858","title":"Tiziana Life Sciences Ltd - Intranasal Foralumab Well Tolerated Over Extended Treatment as of March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636623858","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636623858?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUASFM8S:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635743428","title":"Tiziana Phase 2 trial for foralumab shows reduced brain inflammation","url":"https://stock-news.laohu8.com/highlight/detail?id=2635743428","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635743428?lang=en_us&edition=fundamental","pubTime":"2026-05-14 21:46","pubTimestamp":1778766365,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) announced initial quantitative PET imaging results from the first two patients with Multiple System Atrophy in a Phase...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tiziana-phase-2-trial-for-foralumab-shows-reduced-brain-inflammation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tiziana-phase-2-trial-for-foralumab-shows-reduced-brain-inflammation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632297640","title":"Tiziana FY25 net loss widens to USD 18.4 million; R&D expense rises to USD 10.28 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632297640","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632297640?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:02","pubTimestamp":1777669336,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences posted a net loss of USD 18.4 million for fiscal 2025.Revenue remained at no revenue from product sales.Research and development expense climbed to USD 10.28 million.January 2026 best-efforts registered direct offering raised gross proceeds of USD 8.8 million, with net proceeds of about USD 8.6 million earmarked to complete Phase 2a trials in na-SPMS and MSA through topline readouts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tiziana Life Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information cont","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL17bK7L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632662525","title":"Tiziana Life Sciences delays filing annual Form 20-F for 2025 fiscal year","url":"https://stock-news.laohu8.com/highlight/detail?id=2632662525","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632662525?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:39","pubTimestamp":1777585194,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences filed notice that its annual report on Form 20-F for fiscal year ended Dec. 31, 2025 will be late.Company expects to file Form 20-F within 15 calendar days after original due date.Delay was attributed to time constraints tied to compiling, distributing, and reviewing required disclosures.Filing stated no significant change in results of operations is expected versus prior-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tiziana Life Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL3qdRTl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627290548","title":"Tiziana Life announces publication of preclinical data in bioRxiv preprint","url":"https://stock-news.laohu8.com/highlight/detail?id=2627290548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627290548?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:01","pubTimestamp":1776340884,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) announces the publication of positive preclinical data in a bioRxiv preprint. The study, titled “Intranasal Anti-CD3 A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tiziana-life-announces-publication-of-preclinical-data-in-biorxiv-preprint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tiziana-life-announces-publication-of-preclinical-data-in-biorxiv-preprint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627229422","title":"Tiziana reports preclinical data showing intranasal foralumab eases Long COVID brain inflammation in mice","url":"https://stock-news.laohu8.com/highlight/detail?id=2627229422","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627229422?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:00","pubTimestamp":1776337241,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences disclosed positive preclinical results for intranasal foralumab in a bioRxiv preprint published April 16, 2026; findings have already been presented in that publication.Mouse-model study showed treatment reduced Long COVID-linked neuroinflammation, supported brain repair processes, and improved cognitive function.Data also indicated Long COVID patients with neurological symptoms had lower circulating regulatory T-cell levels, supporting clinical relevance of immune-modulating approach.Tiziana positioned results as mechanistic support for ongoing intranasal foralumab development across multiple neuroinflammatory and neurodegenerative programs.Company noted prior expanded-access use in non-active secondary progressive multiple sclerosis showed favorable safety with signals of clinical benefit.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL9W23dk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014021.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","BK4585","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","BK4588","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","TLSA","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627294212","title":"Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-Cd3 Antibody Attenuates Long Covid Neuroinflammation and Improves Cognitive Function","url":"https://stock-news.laohu8.com/highlight/detail?id=2627294212","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627294212?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:00","pubTimestamp":1776337200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUA7R85QD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627410793","title":"Tiziana presents Phase 2a intranasal foralumab MSA trial poster at World Parkinson Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2627410793","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627410793?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:01","pubTimestamp":1776164494,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences flagged a late-breaking poster on its Phase 2a trial of intranasal foralumab in Multiple System Atrophy , scheduled for presentation at 7th World Parkinson Congress on May 24-27, 2026.Poster will outline trial design and rationale, not clinical results.Study tests whether intranasal foralumab can reduce neuroinflammation tied to disease progression in MSA, condition with no approved disease-modifying therapy.Open-label Phase 2a trial plans to enroll up to 10 patients for 6 months of dosing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL4NPVyf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624971945","title":"Tiziana says preclinical data show intranasal foralumab reverses brain aging, boosts cognition","url":"https://stock-news.laohu8.com/highlight/detail?id=2624971945","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624971945?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:00","pubTimestamp":1775041231,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences reported positive preclinical results for intranasal foralumab in an aging model, positioning nasal anti-CD3 as potential approach for age-related cognitive impairment.Data were presented in April 2026, showing treatment reversed key aspects of brain aging and improved cognition.Study indicated reduced neuroinflammation tied to microglial activation, supporting a mechanism aimed at lowering inflammation-linked cognitive decline.Results also pointed to increased hippocampal neurogenesis and reduced cellular senescence, suggesting potential to support brain repair processes.Tiziana highlighted ongoing clinical programs for intranasal foralumab across several neurodegenerative indications while expanding preclinical work in aging.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL2WqtzJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU0314104364.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","TLSA","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4139","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4585","BK4588","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620153294","title":"Tiziana Life Sciences Ltd. Director and 10% Owner Gabriele M. Cerrone Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620153294","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620153294?lang=en_us&edition=fundamental","pubTime":"2026-03-19 09:18","pubTimestamp":1773883129,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences reported an initial statement of beneficial ownership for director and 10% owner Gabriele Cerrone. The filing reported 44.65 million shares of common stock owned directly by Cerrone. It also listed stock options for 1.63 million shares with an exercise price of USD 0.88 and an expiration date of May 6, 2028. Additional option grants covered 250,000 shares each at an exercise price of USD 0.71, expiring May 3, 2034.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tiziana Life Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL9vS4DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614084952","title":"BUZZ-Tiziana Life Sciences rises as nasal MS drug shows promise in early study","url":"https://stock-news.laohu8.com/highlight/detail?id=2614084952","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614084952?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:33","pubTimestamp":1772022837,"startTime":"0","endTime":"0","summary":"BUZZ-Tiziana Life Sciences rises as nasal MS drug shows promise in early study ** Shares of biotech firm Tiziana Life Sciences TLSA.O rise 3% to $1.36 premarket     ** Co says its experimental nasal drug for multiple sclerosis showed early signs of reducing brain inflammation in a small study** Multiple sclerosis is an autoimmune nerve disorder where the immune system attacks the protective coating around nerves, disrupting signals between the brain and body** Co says all 10 patients in the early study had stable or improved disease with no serious side effects** Study showed reduced brain inflammation on scans and spinal fluid changes linked to lower inflammation and improved nerve protection, per co** Co is testing the drug in a larger mid-stage trial with results expected in 1H 2026 - TLSA** Shares up ~114% in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL4N3ZL13Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614027089","title":"Tiziana reports biomarker data linking nasal foralumab to reduced CSF inflammation and microglial PET signal in na-SPMS patients with PIRA","url":"https://stock-news.laohu8.com/highlight/detail?id=2614027089","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614027089?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:00","pubTimestamp":1772020823,"startTime":"0","endTime":"0","summary":"Tiziana reports biomarker data linking nasal foralumab to reduced CSF inflammation and microglial PET signal in na-SPMS patients with PIRA. Tiziana Life Sciences Ltd. reported new biomarker findings from an open-label expanded-access program evaluating intranasal foralumab, an anti-CD3 monoclonal antibody, in 10 patients with non-active secondary progressive multiple sclerosis with progression independent of relapse activity. The results were already presented in a late-breaking poster by investigators from Brigham and Women’s Hospital and included paired CSF proteomics and [F-18]PBR06-PET assessments showing reduced PET measures of microglial activation and proteomic shifts consistent with decreased inflammatory markers and increased neuroprotective proteins, with no serious treatment-related adverse events reported. The company also said a randomized, double-blind, placebo-controlled Phase 2a trial in na-SPMS is ongoing, with top-line data expected in the first half of 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL11LW4g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4112","SG9999014021.USD","TLSA","LU2210150020.SGD","BK4588","LU2095319765.USD","IE00B3QW5Z07.USD","NDAQ","BK4585","IE00BKPKM429.USD","SG9999014039.USD","BK4139","IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014005.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614089453","title":"Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates Csf Inflammation, Upregulates Neuroprotective Pathways, and Correlates With Reduced Microglial Activation on Pet Scans in Na-Spms Patients With Pira","url":"https://stock-news.laohu8.com/highlight/detail?id=2614089453","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614089453?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:00","pubTimestamp":1772020803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nTUAC4CLX2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}